Jazz Pharmaceuticals plc (J7Z) — Cash Flow Reinvestment Rate
Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting €239.70 Million (capex €19.70 Million plus investments €220.00 Million) from operating cash flow of €408.20 Million. See J7Z cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jazz Pharmaceuticals plc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Jazz Pharmaceuticals plc across 13 annual periods. For the full cash flow conversion analysis, see J7Z cash flow conversion.
Annual Cash Flow Reinvestment Rate for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals plc. See J7Z free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €680.03 Million | €1.36 Billion | €209.75 Million | ▲ +37.8% |
| 2024 | 0.36x | €508.19 Million | €1.40 Billion | €48.07 Million | ▲ +143.8% |
| 2023 | 0.15x | €163.06 Million | €1.09 Billion | €42.96 Million | ▲ +531.4% |
| 2022 | 0.02x | €30.08 Million | €1.27 Billion | €29.05 Million | ▼ -98.3% |
| 2021 | 1.41x | €1.10 Billion | €778.51 Million | €27.64 Million | ▲ +92.5% |
| 2020 | 0.73x | €657.68 Million | €899.65 Million | €15.00 Million | ▲ +425.4% |
| 2019 | 0.14x | €108.03 Million | €776.40 Million | €40.13 Million | ▼ -66.4% |
| 2018 | 0.41x | €331.29 Million | €798.90 Million | €20.37 Million | ▲ +56.2% |
| 2017 | 0.27x | €183.95 Million | €693.09 Million | €28.95 Million | ▼ -91.9% |
| 2016 | 3.26x | €1.93 Billion | €592.39 Million | €181.58 Million | ▲ +1612.7% |
| 2015 | 0.19x | €101.23 Million | €531.94 Million | €35.96 Million | ▼ -23.7% |
| 2014 | 0.25x | €101.62 Million | €407.61 Million | €36.35 Million | ▼ -4.4% |
| 2013 | 0.26x | €75.25 Million | €288.43 Million | €9.98 Million | — |